Literature DB >> 16038400

Characterization of an extracellular serine protease of Leishmania (Leishmania) amazonensis.

R E Silva-Lopez1, M G Pinto Coelho, S G De Simone.   

Abstract

A serine protease was purified 942-fold from culture supernatant of L. amazonensis promastigotes using (NH4)2SO4 precipitation followed by affinity chromatography on aprotinin-agarose and continuous elution electrophoresis by Prep Cell, yielding a total recovery of 61%. The molecular mass of the active enzyme estimated by SDS-PAGE under conditions of reduction was 56 kDa and 115 kDa under conditions of non-reduction, suggesting that the protease is a dimeric protein. Additionally, it was found to be a non-glycosylated enzyme, with a pI of 5.0. The optimal pH and temperature of the enzyme were 7.5 and 28 degrees C respectively, using alpha-N-rho-tosyl-L-arginine-methyl ester (L-TAME) as substrate. Assays of thermal stability indicated that 61% of the enzyme activity was preserved after 1 h of pre-treatment at 42 degrees C. Haemoglobin, bovine serum albumin (BSA), ovalbumin, fibrinogen, collagen, gelatin and peptide substrates containing arginine in an ester bond and amide substrates containing hydrophobic residues at the P1 site were hydrolysed by this extracellular protease. The insulin beta-chain was also hydrolysed by the enzyme and many peptidic bonds were susceptible to the protease action, and 4 of them (L11-V12, E3-A14, L15-Y16 and Y16-L17) were identified. Inhibition studies suggested that the enzyme belongs to the serine protease class inhibited by calcium and manganese and activated by zinc. These findings show that this enzyme of L. amazonensis is a novel serine protease, which differs from all known flagellate proteases characterized.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16038400     DOI: 10.1017/s0031182004006675

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  10 in total

1.  Epoxy-α-lapachone has in vitro and in vivo anti-leishmania (Leishmania) amazonensis effects and inhibits serine proteinase activity in this parasite.

Authors:  Franklin Souza-Silva; Saulo Cabral Bourguignon; Bernardo Acácio Santini Pereira; Luzia Monteiro de Castro Côrtes; Luiz Filipe Gonçalves de Oliveira; Andrea Henriques-Pons; Lea Cysne Finkelstein; Vitor Francisco Ferreira; Paula Fernandes Carneiro; Rosa Teixeira de Pinho; Ernesto Raul Caffarena; Carlos Roberto Alves
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

2.  Leishmania infantum chagasi: a genome-based approach to identification of excreted/secreted proteins.

Authors:  Sruti DebRoy; Alexandra B Keenan; Norikiyo Ueno; Selma M B Jeronimo; John E Donelson; Mary E Wilson
Journal:  Exp Parasitol       Date:  2010-06-11       Impact factor: 2.011

3.  Serine protease activities in Leishmania (Leishmania) chagasi promastigotes.

Authors:  Raquel Elisa da Silva-López; Tatiana Resende dos Santos; José Andrés Morgado-Díaz; Marcelo Neves Tanaka; Salvatore Giovanni de Simone
Journal:  Parasitol Res       Date:  2010-07-29       Impact factor: 2.289

4.  Study of protease activity from Aspergillus awamori INCQS2B.361U2/1 extracellular fraction and modification of culture medium composition to isolate a novel aspartic protease.

Authors:  Raquel Elisa da Silva-López; Thayane Aparecida Alves de Araujo; Hélvio José Jalles Monteiro; Érika Maria Gomes Ferreira Teixeira; Lucas Tupi; Elba Pinto da Silva Bon
Journal:  Braz J Microbiol       Date:  2022-04-11       Impact factor: 2.214

5.  Identification, purification, and characterization of a secretory serine protease in an Indian strain of Leishmania donovani.

Authors:  Rajdeep Choudhury; Siddhartha Kumar Bhaumik; Tripti De; Tapati Chakraborti
Journal:  Mol Cell Biochem       Date:  2008-06-29       Impact factor: 3.396

6.  Effects of serine protease inhibitors on viability and morphology of Leishmania (Leishmania) amazonensis promastigotes.

Authors:  R E Silva-Lopez; J A Morgado-Díaz; M A Chávez; S Giovanni-De-Simone
Journal:  Parasitol Res       Date:  2007-08-29       Impact factor: 2.289

7.  In situ immunolocalization and stage-dependent expression of a secretory serine protease in Leishmania donovani and its role as a vaccine candidate.

Authors:  Rajdeep Choudhury; Partha Das; Siddhartha Kumar Bhaumik; Tripti De; Tapati Chakraborti
Journal:  Clin Vaccine Immunol       Date:  2010-01-27

8.  Enhancement of experimental cutaneous leishmaniasis by Leishmania extract: identification of a disease-associated antibody specificity.

Authors:  Virgínia M G Silva; Cíntia F de-Araújo; Isabela C Navarro; Pablo R S Oliveira; Lain Pontes-de-Carvalho
Journal:  BMC Res Notes       Date:  2015-05-14

9.  Intranasal vaccination with extracellular serine proteases of Leishmania amazonensis confers protective immunity to BALB/c mice against infection.

Authors:  Herbert Leonel de Matos Guedes; Beatriz Lilian da Silva Costa; Suzana Passos Chaves; Daniel Cláudio de Oliveira Gomes; Joshua Daniel Nosanchuk; Salvatore Giovanni De Simone; Bartira Rossi-Bergmann
Journal:  Parasit Vectors       Date:  2014-09-19       Impact factor: 3.876

10.  Proteases from Canavalia ensiformis: Active and Thermostable Enzymes with Potential of Application in Biotechnology.

Authors:  Rayane Natshe Gonçalves; Suellen Duarte Gozzini Barbosa; Raquel Elisa da Silva-López
Journal:  Biotechnol Res Int       Date:  2016-08-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.